Imperial College London

Professor Hani Gabra

Faculty of MedicineDepartment of Surgery & Cancer

Emeritus Professor of Medical Oncology
 
 
 
//

Contact

 

h.gabra Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

Garry Weston CentreCancer CentreHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Herzog:2023:10.1016/j.ygyno.2023.01.003,
author = {Herzog, TJ and Pignata, S and Ghamande, SA and Rubio, M-J and Fujiwara, K and Vulsteke, C and Armstrong, DK and Sehouli, J and Coleman, RL and Gabra, H and Scambia, G and Monk, BJ and Arranz, JA and Ushijima, K and Hanna, R and Zamagni, C and Wenham, RM and Gonzalez-Martin, A and Slomovitz, B and Jia, Y and Ramsay, L and Tewari, KS and Weil, SC and Vergote, IB},
doi = {10.1016/j.ygyno.2023.01.003},
journal = {GYNECOLOGIC ONCOLOGY},
pages = {300--308},
title = {Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer},
url = {http://dx.doi.org/10.1016/j.ygyno.2023.01.003},
volume = {170},
year = {2023}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Herzog,TJ
AU - Pignata,S
AU - Ghamande,SA
AU - Rubio,M-J
AU - Fujiwara,K
AU - Vulsteke,C
AU - Armstrong,DK
AU - Sehouli,J
AU - Coleman,RL
AU - Gabra,H
AU - Scambia,G
AU - Monk,BJ
AU - Arranz,JA
AU - Ushijima,K
AU - Hanna,R
AU - Zamagni,C
AU - Wenham,RM
AU - Gonzalez-Martin,A
AU - Slomovitz,B
AU - Jia,Y
AU - Ramsay,L
AU - Tewari,KS
AU - Weil,SC
AU - Vergote,IB
DO - 10.1016/j.ygyno.2023.01.003
EP - 308
PY - 2023///
SN - 0090-8258
SP - 300
TI - Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
T2 - GYNECOLOGIC ONCOLOGY
UR - http://dx.doi.org/10.1016/j.ygyno.2023.01.003
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000989738900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 170
ER -